Patent Cases filed in the Third Circuit Courts
Cases 1 - 10 of 121
RSS Feed | View as table | Sort by last update
Par Pharmaceutical, Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00866
Plaintiff: Par Pharmaceutical, Inc. and Epic Par Innovation Company, LLC
Defendant: Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NEXUS PHARMACEUTICALS, INC. v. NEVAKAR, INC. et al
as 1:2022cv06030
Plaintiff: NEXUS PHARMACEUTICALS, INC.
Defendant: NEVAKAR, INC., NEVAKAR INJECTABLES, INC., PAR STERILE PRODUCTS, LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NEXUS PHARMACEUTICALS, INC. v. NEVAKAR, INC. et al We have downloadable decisions or orders for this case
as 1:2022cv05683
Plaintiff: NEXUS PHARMACEUTICALS, INC.
Defendant: NEVAKAR, INC., NEVAKAR INJECTABLES, INC., PAR STERILE PRODUCTS, LLC and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Takeda Pharmaceuticals U.S.A., Inc. v. Mylan Pharmaceuticals Inc. We have downloadable decisions or orders for this case
as 1:2019cv02216
Defendant: Mylan Pharmaceuticals Inc.
Plaintiff: Takeda Pharmaceuticals U.S.A., Inc.
3Rd Party Defendant: Hikma Pharmaceuticals International Limited and Hikma Pharmaceuticals USA Inc.
Intervenor: Par Pharmaceutical Inc.
Cause Of Action: 35 U.S.C. § 271
CELGENE CORPORATION v. PAR PHARMACEUTICAL, INC. et al
as 2:2017cv03159
Plaintiff: CELGENE CORPORATION
Defendant: PAR PHARMACEUTICAL, INC., PAR PHARMACEUTICAL COMPANIES, INC., TEVA PHARMACEUTICALS USA, INC. and others
Cause Of Action: 35 U.S.C. § 271
Eli Lilly and Company et al v. Par Pharmaceutical, Inc. et al
as 1:2017cv00456
Plaintiff: Eli Lilly and Company , Eli Lilly Export S.A. and Acrux DDS Pty Ltd.
Defendant: Par Pharmaceutical, Inc. and Par Pharmaceutical Companies, Inc.
Cause Of Action: 35 U.S.C. § 271
Shire-NPS Pharmaceuticals, Inc. v. Ambio, Inc. et al
as 1:2017cv00397
Plaintiff: Shire-NPS Pharmaceuticals, Inc.
Defendant: Ambio, Inc. , AmbioPharm, Inc. , Par Pharmaceutical Companies, Inc. and others
Cause Of Action: 35 U.S.C. § 271
Pfizer Inc. et al v. Par Pharmaceutical, Inc.
as 1:2017cv00342
Plaintiff: Pfizer Inc. , Pfizer Limited and Pfizer Ireland Pharmaceuticals
Defendant: Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271
Sanofi-Aventis U.S. LLC et al v. Par Pharmaceutical, Inc. et al
as 1:2017cv00040
Plaintiff: Sanofi-Aventis U.S. LLC , Aventisub LLC , Sanofi and others
Defendant: Par Pharmaceutical, Inc. , Par Pharmaceutical Companies, Inc. and Par Formulations Private Limited
Cause Of Action: 35 U.S.C. § 271
Aptalis Pharma Canada ULC et al v. Par Pharmaceutical, Inc.
as 1:2016cv01069
Plaintiff: Aptalis Pharma Canada ULC, Forest Laboratories, LLC and Allergan USA, Inc.
Defendant: Par Pharmaceutical, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.

Why Is My Information Online?